Volume: 5 Issue: 3
Year: 2017, Page: 62-67,
Objective: Cardiac Autonomic neuropathy is one of the complications in diabetic patients. This study intends to detect the prevalence of QTc prolongation in diabetic patients as well as its relationship with cardiac autonomic neuropathy.
Materials and Methods :The present study was conducted on 50 diabetic patients. Cardiac autonomic neuropathy was assessed by non-invasive tests: Deep breathing test, Valsalva ratio ,Immediate heart rate response to standing 30:15,B.P rise with sustained hand grip and postural hypotension. Scoring and grading were done for cardiac autonomic neuropathy . Even QT interval and QTc interval were determined.
Results : Out of 50 diabetic patients, 22(44%) were males and 28 (56%) females. 26 patients (52%) having grade I cardiac autonomic neuropathy had no prolonged QTc interval . While, 24 patients (48%) had QTc prolonged were associated with grade II, III and IV cardiac autonomic neuropathy. The sensitivity and specificity of prolonged QTc were 46% and 100%, respectively.
Conclusion : QTc prolongation correlated positivity with degree of cardiac autonomic neuropathy in diabetic patients.
Keywords: Diabetes mellitus, Cardiac autonomic neuropathy, QTc interval
1. Khandoker AH, Jelinek HF, Palaniswami M. Identifying diabetic patients with cardiac autonomic neuropathy by heart rate complexity analysis. Biomed Eng Online. 2009 ;8:3. doi: 10.1186/1475-925X-8-3.
2. Flugelman MY, Kauher Y, Abinader EG, Barzilai D. Rest. ECG patterns in diabetics without evidence of IHD. Diabetes1980; 29 (suppl 2): 76A
3. Kahn JK, Sisson JC, Vinik AI. QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab. 1987 ;64(4):751-4.
4. Jermendy G. QT prolongation and sudden unexpected death. Lancet. 1994 19;343(8899):742.
5. Bellavere F, Ferri M, Guarini L, Bax G, Piccoli A, Cardone C, and Fedele D .Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death? Br Heart J. 1988 ; 59(3): 379–383.
6. Hilsted J. Pathology in diabetic autonomic neuropathy. Diabetes.1982; 31:730.
7. Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortility in TYPE 1diabetics patients with diabetic nephropathy. Diabetes care 2006; 29:334-9.
8. Ewing DJ, Campbell IW, Clark BF. The natural history of diabetic autonomic neuropathy. QJ Med 1980; 49:95-108.
9. Bellavere F, Bosello G, Fedele D, Cardone C, and Ferri M. Diagnosis and Management of diabetic autonomic neuropathy Br. Med. J. 1983:287:61.
10. Lakhotia M, Shah PK, Vyas R, Jain SS, Yadav A, Parihar MK. Clinical dysantonomia in DM – a study with seven autonomic reflex function test. J Assoc Physicians India. 1997;45:271-274.
11. Bathwal S.P. et al. QTc prolongation is diabetes mellitus – an indicator of Cardiac autonomic neuropathy. JAPI1997;45(1):15-17.
12. Ewing DJ, Campbell IW, Clarke BF. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med. 1980 ;92(2 Pt 2):308-11.
13. Sucharita S, Ganapathi Bantwal, Jyothi Idiculla, Vageesh Ayyar, and Mario Vaz. Autonomic nervous system function in type 2 diabetes using conventional clinical autonomic tests, heart rate and blood pressure variability measures. Indian J Endocrinol Metab. 2011; 15(3): 198–203.
14. Gonin JM, Kadrofske MM, Schmaltz S, Bastyr EJ 3rd, Vinik AI.Corrected Q-T interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus. Diabetes Care. 1990;13(1):68-71.
15. Veglio M, Chinaglia A, Borra M, Perin PC. Does abnormal QT interval prolongation reflect autonomic dysfunction in diabetic patients? QTc interval measure versus standardized tests in diabetic autonomic neuropathy. Diabet Med. 1995 ;12(4):302-6.
Natarajan N, Ramaiyah M S. Study of relationship between QTC prolongation and cardiac autonomic neuropathy in Diabetes mellitus. Perspectives in Medical Research 2017;5(3):62-67.